Generics 12

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tafamidis manufacturers

12 products found

Filters

12 products found

tafamidis

Capsules 61 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Cardiomyopathy;
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

tafamidis

Capsules 61 mg, 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #21467

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.

Manufacturer usually replies in 22 days

tafamidis + meglumine

Oral solution 10 mg/ml , 20 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #31060
This company is a contract development and manufacturing organization (CDMO) specializing in the production of high-potency and oncological oral liquid formulations. Established in recent years, the company operates primarily in the European Union and North America. Their core expertise lies in developing and manufacturing customized, high-quality, and cost-effective oral liquid products for patients requiring dose titration and tailored treatment plans. Their production lines focus on oncology, specifically targeting high-potency medications for oral administration. This CDMO has a strong emphasis on quality, with a state-of-the-art facility and robust quality systems. Their services encompass the entire drug development process from formulation and analytical development to clinical trials, regulatory support, and commercial manufacturing. This company is actively expanding its GMP-approved manufacturing facilities and strives to provide a full range of services to support partners in overcoming the unique challenges of developing high-potency oral liquid formulations.

Manufacturer usually replies in 86 days

Want to see all 12 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible